Ran-IN-1
Ran-IN-1 (Compound M36) is an orally active and selective Ran GTPase inhibitor. Ran-IN-1 binds to the GDP-bound form of Ran (RanGDP) at the allosteric switch II pocket with high specificity, stabilizing the inactive state and reducing the active Ran-GTP population. Ran-IN-1 induces apoptosis and represses DNA repair pathways like HR and NHEJ in epithelial ovarian cancer (EOC) cells. Ran-IN-1 is promising for research of EOC, particularly high-grade serous carcinoma[1].
Product Specifications
CAS Number
[2301869-11-2]
UNSPSC
12352005
Target
Apoptosis; Arf Family GTPase
Related Pathways
Apoptosis; GPCR/G Protein
Field of Research
Cancer
Smiles
FC1=CC=C(COC[C@@H]2[C@@H](OCC3=CC=C(F)C=C3)[C@@H](OCC4=CC=C(F)C=C4)[C@H](C(N)=S)O2)C=C1
Molecular Formula
C27H26F3NO4S
Molecular Weight
517.56
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human OAZ2 shRNA (UAS) - Lentiviral human OAZ2 shRNA (UAS) plasmid
SLC25A25 (Calcium-binding Mitochondrial Carrier Protein SCaMC-2, Mitochondrial ATP-Mg/Pi Carrier Protein 3, Mitochondrial Ca (2+) -dependent Solute Carrier Protein 3, Small Calcium-binding Mitochondrial Carrier Protein 2, Solute Carrier Family 25 Member 25, APC3, KIAA1896, MCSC3, SCAMC2, UNQ549/PRO1106)
